[Overview of vinorelbine for metastatic breast cancer].
Adachi
I
I
Division of Breast Cancer/Endocrinology, National Cancer Center Central Hospital.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008942:Mitoxantrone / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D015251:Epirubicin; D014747:Vinblastine; D004317:Doxorubicin; D008942:Mitoxantrone; D017239:Paclitaxel; D000077235:Vinorelbine